AK 3012A proprietary topical formulation. Upon subcutaneous administration, the active ingredient in AK 3012 may inhibit actinic keratosis.Check for active clinical trials using this agentView this agent in the NCI ThesaurusSearch NCI's Drug DictionaryStarts withContainsPlease enter up to 30 characters for your searchBrowse:ABCDEFGHIJKLMNOPQRSTUVWXYZ#
